A Randomized 3-Arm Phase Ii Study To Determine The Most Promising Postgrafting Immunosuppression For Prevention Of Acute Graft-Versus-Host Disease (Gvhd) After Unrelated Donor Hematopoietic Cell Transplantation (Hct) Using Nonmyeloablative Conditioning For Patients With Hematologic Malignancies: A Multi-Center Trial